TY  - GEN
AU  - Rudin,Charles M
AU  - Mauer,Ann
AU  - Smakal,Martin
AU  - Juergens,Rosalyn
AU  - Spelda,Stanislav
AU  - Wertheim,Michael
AU  - Coates,Andrew
AU  - McKeegan,Evelyn
AU  - Ansell,Peter
AU  - Zhou,Xiangdong
AU  - Qian,Jane
AU  - Pradhan,Rajendra
AU  - Dowell,Barry
AU  - Krivoshik,Andrew
AU  - Gordon,Gary
TI  - Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer
SN  - 1527-7755
PY  - 2011///0509
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Biomarkers, Tumor
KW  - blood
KW  - Carcinoma, Non-Small-Cell Lung
KW  - Czech Republic
KW  - Disease-Free Survival
KW  - Double-Blind Method
KW  - Female
KW  - Glutamates
KW  - administration & dosage
KW  - Guanine
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Pemetrexed
KW  - Proportional Hazards Models
KW  - Risk Assessment
KW  - Risk Factors
KW  - Sulfonamides
KW  - Time Factors
KW  - Treatment Outcome
KW  - United States
N1  - Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2010.32.5944
ER  -